Salmond Nikki, Williams Karla C
University of British Columbia, Faculty of Pharmaceutical Sciences Vancouver V6T 1Z3 Canada
Nanoscale Adv. 2021 Feb 16;3(7):1830-1852. doi: 10.1039/d0na00676a. eCollection 2021 Apr 6.
Extracellular vesicles (EVs) are nanometer sized lipid enclosed particles released by all cell types into the extracellular space and biological fluids , and into cell culture media . An important physiological role of EVs is cell-cell communication. EVs interact with, and deliver, their contents to recipient cells in a functional capacity; this makes EVs desirable vehicles for the delivery of therapeutic cargoes. In addition, as EVs contain proteins, lipids, glycans, and nucleic acids that reflect their cell of origin, their potential utility in disease diagnosis and prognostication is of great interest. The number of published studies analyzing EVs and their contents in the pre-clinical and clinical setting is rapidly expanding. However, there is little standardization as to what techniques should be used to isolate, purify and characterize EVs. Here we provide a comprehensive literature review encompassing the use of EVs as diagnostic and prognostic biomarkers in cancer. We also detail their use as therapeutic delivery vehicles to treat cancer in pre-clinical and clinical settings and assess the EV isolation and characterization strategies currently being employed. Our report details diverse isolation strategies which are often dependent upon multiple factors such as biofluid type, sample volume, and desired purity of EVs. As isolation strategies vary greatly between studies, thorough EV characterization would be of great importance. However, to date, EV characterization in pre-clinical and clinical studies is not consistently or routinely adhered to. Standardization of EV characterization so that all studies image EVs, quantitate protein concentration, identify the presence of EV protein markers and contaminants, and measure EV particle size and concentration is suggested. Additionally, the use of RNase, DNase and protease EV membrane protection control experiments is recommended to ensure that the cargo being investigated is truly EV associated. Overall, diverse methodology for EV isolation is advantageous as it can support different sample types and volumes. Nevertheless, EV characterization is crucial and should be performed in a rigorous manor.
细胞外囊泡(EVs)是由所有细胞类型释放到细胞外空间、生物流体以及细胞培养基中的纳米级脂质包裹颗粒。EVs的一个重要生理作用是细胞间通讯。EVs以功能性方式与受体细胞相互作用并传递其内容物;这使得EVs成为递送治疗性货物的理想载体。此外,由于EVs含有反映其来源细胞的蛋白质、脂质、聚糖和核酸,它们在疾病诊断和预后中的潜在用途备受关注。在临床前和临床环境中分析EVs及其内容物的已发表研究数量正在迅速增加。然而,对于应使用何种技术来分离、纯化和表征EVs,几乎没有标准化。在此,我们提供了一篇全面的文献综述,涵盖了EVs作为癌症诊断和预后生物标志物的应用。我们还详细介绍了它们在临床前和临床环境中作为治疗性递送载体治疗癌症的用途,并评估了目前正在采用的EV分离和表征策略。我们的报告详细介绍了多种分离策略,这些策略通常取决于多种因素,如生物流体类型、样品体积和所需的EVs纯度。由于不同研究之间的分离策略差异很大,因此对EVs进行全面表征非常重要。然而,迄今为止,临床前和临床研究中的EV表征并未始终如一地或常规地遵循。建议对EV表征进行标准化,以便所有研究都能对EVs进行成像、定量蛋白质浓度、鉴定EV蛋白质标志物和污染物的存在,并测量EV颗粒大小和浓度。此外,建议使用核糖核酸酶、脱氧核糖核酸酶和蛋白酶进行EV膜保护对照实验,以确保所研究的货物确实与EV相关。总体而言,多样化的EV分离方法是有利的,因为它可以支持不同的样品类型和体积。然而,EV表征至关重要,应该以严谨的方式进行。